Welcome to LookChem.com Sign In|Join Free

CAS

  • or

146142-94-1

Post Buying Request

146142-94-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

146142-94-1 Usage

Uses

(4S)-4-Hydroxy-4-(1H-indol-3-ylmethyl)-L-Glutamic Acid is a sweetener used in a study to analyze the anatomy of binding sites of human T1R2 and T1R3 sweet receptors.

Check Digit Verification of cas no

The CAS Registry Mumber 146142-94-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,6,1,4 and 2 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 146142-94:
(8*1)+(7*4)+(6*6)+(5*1)+(4*4)+(3*2)+(2*9)+(1*4)=121
121 % 10 = 1
So 146142-94-1 is a valid CAS Registry Number.

146142-94-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S,4S)-4-amino-2-hydroxy-2-(1H-indol-3-ylmethyl)pentanedioic acid

1.2 Other means of identification

Product number -
Other names (S)-4-Hydroxy-4-(1H-indol-3-ylmethyl)-L-glutamic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:146142-94-1 SDS

146142-94-1Synthetic route

(2S,4S)-4-Amino-2-(1H-indol-3-ylmethyl)-5-oxo-tetrahydro-furan-2-carboxylic acid

(2S,4S)-4-Amino-2-(1H-indol-3-ylmethyl)-5-oxo-tetrahydro-furan-2-carboxylic acid

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
With sodium hydroxide In methanol92%
With sodium hydroxide In methanol; water at 20℃; for 6h;54 mg
Stage #1: (2S,4S)-4-Amino-2-(1H-indol-3-ylmethyl)-5-oxo-tetrahydro-furan-2-carboxylic acid With water; potassium hydroxide In methanol at 25℃; for 1h; Inert atmosphere; Large scale reaction;
Stage #2: With acetic acid In methanol pH=6.5; Large scale reaction;
Stage #3: With acetic acid In methanol pH=6.5; Large scale reaction; optical yield given as %ee;
193 g
4-amino-2-hydroxy-2-(1H-indol-3-ylmethyl)-pentanedioic acid
855433-72-6

4-amino-2-hydroxy-2-(1H-indol-3-ylmethyl)-pentanedioic acid

A

(2S,4R) 4-hydroxy-4-(3-indolylmethyl)-2-aminoglutaric acid
400769-77-9

(2S,4R) 4-hydroxy-4-(3-indolylmethyl)-2-aminoglutaric acid

B

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
RP18-HPLC resolution;
4-hydroxy-4-(3-indolylmethyl)-2-ketoglutaric acid
551958-84-0

4-hydroxy-4-(3-indolylmethyl)-2-ketoglutaric acid

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
With pyridoxal 5'-phosphate; tris hydrochloride; monosodium glutamate; Aeromonas hydrophila IFO3820 In water; toluene at 30℃; for 16h; pH=7.6; Product distribution / selectivity; Enzymatic reaction; Culture medium;
With pyridoxal 5'-phosphate; tris hydrochloride; monosodium glutamate; Agrobacterium tumefaciens IFO3058 In water; toluene at 30℃; for 16h; pH=7.6; Product distribution / selectivity; Enzymatic reaction; Culture medium;
With pyridoxal 5'-phosphate; tris hydrochloride; monosodium glutamate; Alcaligenes faecalis ATCC8750 In water; toluene at 30℃; for 16h; pH=7.6; Product distribution / selectivity; Enzymatic reaction; Culture medium;
L-Tryptophan
73-22-3

L-Tryptophan

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
With potassium phosphate; pyridoxal 5'-phosphate; magnesium chloride; Comamonas testosteroni proA Aldolase; HIS6-HEXaspC aminotransferase In water for 27 - 29h; pH=7.8; Product distribution / selectivity; Enzymatic reaction;
With potassium phosphate; pyridoxal 5'-phosphate; magnesium chloride; Comamonas testosteroni proA Aldolase; HIS6-HEXaspC aminotransferase In water for 27 - 29h; pH=7.8; Product distribution / selectivity; Enzymatic reaction;
L-Tryptophan
73-22-3

L-Tryptophan

A

(S)-2-hydroxy-2-(1H-indol-3-ylmethyl)-4-oxo-pentanedioic acid
914081-89-3

(S)-2-hydroxy-2-(1H-indol-3-ylmethyl)-4-oxo-pentanedioic acid

B

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
With potassium phosphate; pyridoxal 5'-phosphate; magnesium chloride; Comamonas testosteroni proA Aldolase; HIS6-HEXaspC aminotransferase In water at 30℃; for 3 - 5h; pH=7.5 - 7.8; Product distribution / selectivity; Enzymatic reaction;
L-alanin
56-41-7

L-alanin

A

(S)-2-hydroxy-2-(1H-indol-3-ylmethyl)-4-oxo-pentanedioic acid
914081-89-3

(S)-2-hydroxy-2-(1H-indol-3-ylmethyl)-4-oxo-pentanedioic acid

B

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Stage #1: L-Tryptophan With potassium phosphate; pyridoxal 5'-phosphate; magnesium chloride; Comamonas testosteroni proA Aldolase; HIS6-HEXaspC aminotransferase In water at 30℃; for 3 - 5h; pH=7.5 - 7.8; Enzymatic reaction;
Stage #2: L-alanin; HIS6-HEXaspC aminotransferase In water at 30℃; pH=7.5 - 7.8; Product distribution / selectivity; Enzymatic reaction;
sodium pyruvate
113-24-6

sodium pyruvate

L-Tryptophan
73-22-3

L-Tryptophan

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
With potassium phosphate; pyridoxal 5'-phosphate; magnesium chloride; Comamonas testosteroni proA Aldolase; HIS6-HEXaspC aminotransferase In water at 30℃; for 21 - 29h; pH=7.8; Product distribution / selectivity; Enzymatic reaction;
3-((2S,4S)-4-Amino-2-hydroxymethyl-5-oxo-tetrahydro-furan-2-ylmethyl)-indole-1-carboxylic acid tert-butyl ester

3-((2S,4S)-4-Amino-2-hydroxymethyl-5-oxo-tetrahydro-furan-2-ylmethyl)-indole-1-carboxylic acid tert-butyl ester

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 15.6 mg / NaHCO3 / acetonitrile; H2O / 24 h / 20 °C
2: 69 percent / PDC / dimethylformamide / 24 h / 20 °C
3: HCO2H; HCl / 4 h / 20 °C
4: 54 mg / NaOH / methanol; H2O / 6 h / 20 °C
View Scheme
2-[(indol-3-yl)methyl]prop-2-en-1-ol
645396-51-6

2-[(indol-3-yl)methyl]prop-2-en-1-ol

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1: CH2Cl2 / 360 h / 20 °C
2: 97 percent / imidaziole / dimethylformamide / 3 h / 20 °C
3: 97 percent / DMAP / acetonitrile / 1 h / 20 °C
4: 100 percent / pyridine*HF / tetrahydrofuran / 1 h / 0 °C
5: H2 / Pd(OH)2/C / methanol / 5 h / 20 °C / atmospheric pressure
6: 15.6 mg / NaHCO3 / acetonitrile; H2O / 24 h / 20 °C
7: 69 percent / PDC / dimethylformamide / 24 h / 20 °C
8: HCO2H; HCl / 4 h / 20 °C
9: 54 mg / NaOH / methanol; H2O / 6 h / 20 °C
View Scheme
Multi-step reaction with 9 steps
1: 98 percent / MgBr2*OEt2 / CH2Cl2 / 84 h / 20 °C
2: 97 percent / imidaziole / dimethylformamide / 3 h / 20 °C
3: 97 percent / DMAP / acetonitrile / 1 h / 20 °C
4: 100 percent / pyridine*HF / tetrahydrofuran / 1 h / 0 °C
5: H2 / Pd(OH)2/C / methanol / 5 h / 20 °C / atmospheric pressure
6: 15.6 mg / NaHCO3 / acetonitrile; H2O / 24 h / 20 °C
7: 69 percent / PDC / dimethylformamide / 24 h / 20 °C
8: HCO2H; HCl / 4 h / 20 °C
9: 54 mg / NaOH / methanol; H2O / 6 h / 20 °C
View Scheme
Multi-step reaction with 9 steps
1: CH2Cl2 / 360 h / 20 °C
2: 97 percent / imidazole / dimethylformamide
3: 97 percent / DMAP / acetonitrile
4: 100 percent / HF*pyridine / tetrahydrofuran
5: H2 / Pd(OH)2/C / methanol
6: acetonitrile
7: 69 percent / PDC / dimethylformamide
8: HCl; HCOOH
9: 92 percent / NaOH / methanol
View Scheme
Multi-step reaction with 9 steps
1: 98 percent / MgBr2*OEt2 / CH2Cl2 / 72 h / 20 °C
2: 97 percent / imidazole / dimethylformamide
3: 97 percent / DMAP / acetonitrile
4: 100 percent / HF*pyridine / tetrahydrofuran
5: H2 / Pd(OH)2/C / methanol
6: acetonitrile
7: 69 percent / PDC / dimethylformamide
8: HCl; HCOOH
9: 92 percent / NaOH / methanol
View Scheme
ethyl 2-((1H-indol-3-yl)methyl)acrylate
87438-91-3

ethyl 2-((1H-indol-3-yl)methyl)acrylate

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1: 85 percent / DIBAL-H / CH2Cl2; hexane / -78 - 20 °C
2: CH2Cl2 / 360 h / 20 °C
3: 97 percent / imidaziole / dimethylformamide / 3 h / 20 °C
4: 97 percent / DMAP / acetonitrile / 1 h / 20 °C
5: 100 percent / pyridine*HF / tetrahydrofuran / 1 h / 0 °C
6: H2 / Pd(OH)2/C / methanol / 5 h / 20 °C / atmospheric pressure
7: 15.6 mg / NaHCO3 / acetonitrile; H2O / 24 h / 20 °C
8: 69 percent / PDC / dimethylformamide / 24 h / 20 °C
9: HCO2H; HCl / 4 h / 20 °C
10: 54 mg / NaOH / methanol; H2O / 6 h / 20 °C
View Scheme
Multi-step reaction with 10 steps
1: 85 percent / DIBAL-H / CH2Cl2; hexane / -78 - 20 °C
2: 98 percent / MgBr2*OEt2 / CH2Cl2 / 84 h / 20 °C
3: 97 percent / imidaziole / dimethylformamide / 3 h / 20 °C
4: 97 percent / DMAP / acetonitrile / 1 h / 20 °C
5: 100 percent / pyridine*HF / tetrahydrofuran / 1 h / 0 °C
6: H2 / Pd(OH)2/C / methanol / 5 h / 20 °C / atmospheric pressure
7: 15.6 mg / NaHCO3 / acetonitrile; H2O / 24 h / 20 °C
8: 69 percent / PDC / dimethylformamide / 24 h / 20 °C
9: HCO2H; HCl / 4 h / 20 °C
10: 54 mg / NaOH / methanol; H2O / 6 h / 20 °C
View Scheme
Multi-step reaction with 11 steps
1: 97 percent / Et3N; 4-DMAP / CH2Cl2 / 20 °C
2: 72 percent / DIBAL-H / CH2Cl2 / -78 °C
3: MgBr2*OEt2 / CH2Cl2 / 96 h / 20 °C
4: 97 percent / imidazole / dimethylformamide
5: 97 percent / DMAP / acetonitrile
6: 100 percent / HF*pyridine / tetrahydrofuran
7: H2 / Pd(OH)2/C / methanol
8: acetonitrile
9: 69 percent / PDC / dimethylformamide
10: HCl; HCOOH
11: 92 percent / NaOH / methanol
View Scheme
(2S,5S,8aS)-2-(hydroxymethyl)-2-[(indol-3-yl)methyl]-5-phenyl-1,5,6,8a-tetrahydro-3,7-dioxaindolizin-8(2H)-one
645396-53-8

(2S,5S,8aS)-2-(hydroxymethyl)-2-[(indol-3-yl)methyl]-5-phenyl-1,5,6,8a-tetrahydro-3,7-dioxaindolizin-8(2H)-one

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: 97 percent / imidaziole / dimethylformamide / 3 h / 20 °C
2: 97 percent / DMAP / acetonitrile / 1 h / 20 °C
3: 100 percent / pyridine*HF / tetrahydrofuran / 1 h / 0 °C
4: H2 / Pd(OH)2/C / methanol / 5 h / 20 °C / atmospheric pressure
5: 15.6 mg / NaHCO3 / acetonitrile; H2O / 24 h / 20 °C
6: 69 percent / PDC / dimethylformamide / 24 h / 20 °C
7: HCO2H; HCl / 4 h / 20 °C
8: 54 mg / NaOH / methanol; H2O / 6 h / 20 °C
View Scheme
Multi-step reaction with 8 steps
1: 97 percent / imidazole / dimethylformamide
2: 97 percent / DMAP / acetonitrile
3: 100 percent / HF*pyridine / tetrahydrofuran
4: H2 / Pd(OH)2/C / methanol
5: acetonitrile
6: 69 percent / PDC / dimethylformamide
7: HCl; HCOOH
8: 92 percent / NaOH / methanol
View Scheme
(2S,4S)-4-(tert-butoxycarbonyl)amino-2-[(1-(tert-butoxycarbonyl)indol-3-yl)methyl]-2-(hydroxymethyl)oxolan-5-one
645396-57-2

(2S,4S)-4-(tert-butoxycarbonyl)amino-2-[(1-(tert-butoxycarbonyl)indol-3-yl)methyl]-2-(hydroxymethyl)oxolan-5-one

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 69 percent / PDC / dimethylformamide / 24 h / 20 °C
2: HCO2H; HCl / 4 h / 20 °C
3: 54 mg / NaOH / methanol; H2O / 6 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1: 69 percent / PDC / dimethylformamide
2: HCl; HCOOH
3: 92 percent / NaOH / methanol
View Scheme
(2S,4S)-4-(tert-butyloxycarbonyl)amino-2-[(1-(tert-butyloxycarbonyl)indol-3-yl)methyl]-5-oxooxolane-2-carboxylic acid
645396-58-3

(2S,4S)-4-(tert-butyloxycarbonyl)amino-2-[(1-(tert-butyloxycarbonyl)indol-3-yl)methyl]-5-oxooxolane-2-carboxylic acid

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: HCO2H; HCl / 4 h / 20 °C
2: 54 mg / NaOH / methanol; H2O / 6 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: HCl; HCOOH
2: 92 percent / NaOH / methanol
View Scheme
(2S,5S,8aS)-2-[(tert-butyl(dimethyl)silyloxy)methyl]-2-[(indol-3-yl)methyl]-2-(hydroxymethyl)-5-phenyl-1,5,6,8a-tetrahydro-3,7-dioxaindolizin-8(2H)-one
645396-59-4

(2S,5S,8aS)-2-[(tert-butyl(dimethyl)silyloxy)methyl]-2-[(indol-3-yl)methyl]-2-(hydroxymethyl)-5-phenyl-1,5,6,8a-tetrahydro-3,7-dioxaindolizin-8(2H)-one

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 97 percent / DMAP / acetonitrile / 1 h / 20 °C
2: 100 percent / pyridine*HF / tetrahydrofuran / 1 h / 0 °C
3: H2 / Pd(OH)2/C / methanol / 5 h / 20 °C / atmospheric pressure
4: 15.6 mg / NaHCO3 / acetonitrile; H2O / 24 h / 20 °C
5: 69 percent / PDC / dimethylformamide / 24 h / 20 °C
6: HCO2H; HCl / 4 h / 20 °C
7: 54 mg / NaOH / methanol; H2O / 6 h / 20 °C
View Scheme
Multi-step reaction with 7 steps
1: 97 percent / DMAP / acetonitrile
2: 100 percent / HF*pyridine / tetrahydrofuran
3: H2 / Pd(OH)2/C / methanol
4: acetonitrile
5: 69 percent / PDC / dimethylformamide
6: HCl; HCOOH
7: 92 percent / NaOH / methanol
View Scheme
(2S,5S,8aS)-2-[(1-(tertbutoxycarbonyl)indol-3-yl)methyl]-2-(hydroxymethyl)-5-phenyl-1,5,6,8a-tetrahydro-3,7-dioxaindolizin-8(2H)-one
645396-54-9

(2S,5S,8aS)-2-[(1-(tertbutoxycarbonyl)indol-3-yl)methyl]-2-(hydroxymethyl)-5-phenyl-1,5,6,8a-tetrahydro-3,7-dioxaindolizin-8(2H)-one

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: H2 / Pd(OH)2/C / methanol / 5 h / 20 °C / atmospheric pressure
2: 15.6 mg / NaHCO3 / acetonitrile; H2O / 24 h / 20 °C
3: 69 percent / PDC / dimethylformamide / 24 h / 20 °C
4: HCO2H; HCl / 4 h / 20 °C
5: 54 mg / NaOH / methanol; H2O / 6 h / 20 °C
View Scheme
Multi-step reaction with 5 steps
1: H2 / Pd(OH)2/C / methanol
2: acetonitrile
3: 69 percent / PDC / dimethylformamide
4: HCl; HCOOH
5: 92 percent / NaOH / methanol
View Scheme
(2S,5S,8aS)-2-[(tert-butyl(dimethyl)silyloxy)methyl]-2-[(1-(tert-butoxycarbonyl)indol-3-yl)methyl]-2-(hydroxymethyl)-5-phenyl-1,5,6,8a-tetrahydro-3,7-dioxaindolizin-8(2H)-one
645396-60-7

(2S,5S,8aS)-2-[(tert-butyl(dimethyl)silyloxy)methyl]-2-[(1-(tert-butoxycarbonyl)indol-3-yl)methyl]-2-(hydroxymethyl)-5-phenyl-1,5,6,8a-tetrahydro-3,7-dioxaindolizin-8(2H)-one

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 100 percent / pyridine*HF / tetrahydrofuran / 1 h / 0 °C
2: H2 / Pd(OH)2/C / methanol / 5 h / 20 °C / atmospheric pressure
3: 15.6 mg / NaHCO3 / acetonitrile; H2O / 24 h / 20 °C
4: 69 percent / PDC / dimethylformamide / 24 h / 20 °C
5: HCO2H; HCl / 4 h / 20 °C
6: 54 mg / NaOH / methanol; H2O / 6 h / 20 °C
View Scheme
Multi-step reaction with 6 steps
1: 100 percent / HF*pyridine / tetrahydrofuran
2: H2 / Pd(OH)2/C / methanol
3: acetonitrile
4: 69 percent / PDC / dimethylformamide
5: HCl; HCOOH
6: 92 percent / NaOH / methanol
View Scheme
(3S)-5-(3-indolylmethyl)-4,5-dihydroisoxazole-3,5-dicarboxylic acid
855436-27-0

(3S)-5-(3-indolylmethyl)-4,5-dihydroisoxazole-3,5-dicarboxylic acid

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 60 percent / Na/Hg / ethanol
2: RP18-HPLC resolution
View Scheme
ethyl (3S)-5-(3-indolylmethyl)-5-carboxy-4,5-dihydroisoxazole-3-carboxylate
855433-63-5

ethyl (3S)-5-(3-indolylmethyl)-5-carboxy-4,5-dihydroisoxazole-3-carboxylate

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: KOH / ethanol; H2O / 2.5 h / 20 °C
2: 60 percent / Na/Hg / ethanol
3: RP18-HPLC resolution
View Scheme
diethyl 5-((1H-indol-3-yl)methyl)-4,5-dihydroisoxazole-3,5-dicarboxylate

diethyl 5-((1H-indol-3-yl)methyl)-4,5-dihydroisoxazole-3,5-dicarboxylate

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: Aspergillus oryzae protease; aq. NaOH / aq. phosphate buffer; toluene / pH 7.0
2: KOH / ethanol; H2O / 2.5 h / 20 °C
3: 60 percent / Na/Hg / ethanol
4: RP18-HPLC resolution
View Scheme
Multi-step reaction with 5 steps
1.1: hydrogen; potassium hydroxide / ethanol / 1.5 h / 21 °C / 1500.15 - 3750.38 Torr / Sealed reactor; Large scale reaction
2.1: hydrogenchloride / methanol / 20 - 45 °C / Large scale reaction
2.2: 1.5 h / 5 - 25 °C / Large scale reaction
2.3: 15 h / 25 °C / Large scale reaction
3.1: protease from Bacillus lichenformis ChiroCLEC-BL / acetonitrile / 19 h / 22 °C / pH 7.5 / aq. phosphate buffer; Large scale reaction; Enzymatic reaction
4.1: palladium 10% on activated carbon; hydrogen; triethylamine / methanol / 1 h / 40 °C / 2250.23 Torr / Sealed vessel; Large scale reaction
5.1: water; potassium hydroxide / methanol / 1 h / 25 °C / Inert atmosphere; Large scale reaction
5.2: pH 6.5 / Large scale reaction
5.3: pH 6.5 / Large scale reaction
View Scheme
3-(2-hydroxymethyl-allyl)-indole-1-carboxylic acid tert-butyl ester
645396-52-7

3-(2-hydroxymethyl-allyl)-indole-1-carboxylic acid tert-butyl ester

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1: MgBr2*OEt2 / CH2Cl2 / 96 h / 20 °C
2: 97 percent / imidazole / dimethylformamide
3: 97 percent / DMAP / acetonitrile
4: 100 percent / HF*pyridine / tetrahydrofuran
5: H2 / Pd(OH)2/C / methanol
6: acetonitrile
7: 69 percent / PDC / dimethylformamide
8: HCl; HCOOH
9: 92 percent / NaOH / methanol
View Scheme
Multi-step reaction with 6 steps
1: MgBr2*OEt2 / CH2Cl2 / 96 h / 20 °C
2: H2 / Pd(OH)2/C / methanol
3: acetonitrile
4: 69 percent / PDC / dimethylformamide
5: HCl; HCOOH
6: 92 percent / NaOH / methanol
View Scheme
3-(2-ethoxycarbonyl-allyl)-indole-1-carboxylic acid tert-butyl ester
645396-50-5

3-(2-ethoxycarbonyl-allyl)-indole-1-carboxylic acid tert-butyl ester

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1: 72 percent / DIBAL-H / CH2Cl2 / -78 °C
2: MgBr2*OEt2 / CH2Cl2 / 96 h / 20 °C
3: 97 percent / imidazole / dimethylformamide
4: 97 percent / DMAP / acetonitrile
5: 100 percent / HF*pyridine / tetrahydrofuran
6: H2 / Pd(OH)2/C / methanol
7: acetonitrile
8: 69 percent / PDC / dimethylformamide
9: HCl; HCOOH
10: 92 percent / NaOH / methanol
View Scheme
Multi-step reaction with 7 steps
1: 72 percent / DIBAL-H / CH2Cl2 / -78 °C
2: MgBr2*OEt2 / CH2Cl2 / 96 h / 20 °C
3: H2 / Pd(OH)2/C / methanol
4: acetonitrile
5: 69 percent / PDC / dimethylformamide
6: HCl; HCOOH
7: 92 percent / NaOH / methanol
View Scheme
3-((2S,4S)-4-Amino-2-hydroxy-2-hydroxymethyl-4-phenethyloxycarbonyl-butyl)-indole-1-carboxylic acid tert-butyl ester

3-((2S,4S)-4-Amino-2-hydroxy-2-hydroxymethyl-4-phenethyloxycarbonyl-butyl)-indole-1-carboxylic acid tert-butyl ester

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: acetonitrile
2: 69 percent / PDC / dimethylformamide
3: HCl; HCOOH
4: 92 percent / NaOH / methanol
View Scheme
(2S,4R) 4-hydroxy-4-(3-indolylmethyl)-2-aminoglutaric acid
400769-77-9

(2S,4R) 4-hydroxy-4-(3-indolylmethyl)-2-aminoglutaric acid

(2S,4R)-monatin
400769-79-1

(2S,4R)-monatin

A

(2R,4R)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
400769-81-5

(2R,4R)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

B

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
With salicylaldehyde; acetic acid In methanol at 65℃; for 143h; pH=5; Product distribution / selectivity;
4-hydroxy-4-(3-indolylmethyl)-2-hydroxyiminoglutaric acid di-ammonium salt

4-hydroxy-4-(3-indolylmethyl)-2-hydroxyiminoglutaric acid di-ammonium salt

A

(2R,4R)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
400769-81-5

(2R,4R)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

B

(2S,4R) 4-hydroxy-4-(3-indolylmethyl)-2-aminoglutaric acid
400769-77-9

(2S,4R) 4-hydroxy-4-(3-indolylmethyl)-2-aminoglutaric acid

C

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

D

(2S,4R)-monatin
400769-79-1

(2S,4R)-monatin

Conditions
ConditionsYield
With ammonia; hydrogen; 5% rhodium-on-charcoal In water at 25℃; under 7500.75 Torr; for 24h; Product distribution / selectivity;
(2R,4S)-4-amino-2-hydroxy-2-(1H-indol-3-ylmethyl)-pentanedioic acid ammonium salt

(2R,4S)-4-amino-2-hydroxy-2-(1H-indol-3-ylmethyl)-pentanedioic acid ammonium salt

(2S,4R)-4-amino-2-hydroxy-2-(1H-indol-3-ylmethyl)-pentanedioic acid ammonium salt

(2S,4R)-4-amino-2-hydroxy-2-(1H-indol-3-ylmethyl)-pentanedioic acid ammonium salt

A

(2R,4R)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
400769-81-5

(2R,4R)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

B

(2S,4R) 4-hydroxy-4-(3-indolylmethyl)-2-aminoglutaric acid
400769-77-9

(2S,4R) 4-hydroxy-4-(3-indolylmethyl)-2-aminoglutaric acid

C

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
With methanol; salicylaldehyde; acetic acid at 80℃; for 16h; Product distribution / selectivity;
isoxazoline diethyl ester

isoxazoline diethyl ester

A

(2R,4R)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
400769-81-5

(2R,4R)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

B

(2S,4R) 4-hydroxy-4-(3-indolylmethyl)-2-aminoglutaric acid
400769-77-9

(2S,4R) 4-hydroxy-4-(3-indolylmethyl)-2-aminoglutaric acid

C

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

D

(2S,4R)-monatin
400769-79-1

(2S,4R)-monatin

Conditions
ConditionsYield
Stage #1: isoxazoline diethyl ester With potassium hydroxide; water; sponge nickel catalyst A-7063 In ethanol for 0.0833333h; Sealed reactor;
Stage #2: With hydrogen In ethanol; water at 20℃; under 3750.38 Torr; for 1.5h; Product distribution / selectivity; Sealed reactor;
Stage #1: isoxazoline diethyl ester With potassium hydroxide; water In ethanol at 20℃;
Stage #2: With hydrogen; sponge nickel catalyst A5200 In ethanol; water at 20℃; under 3750.38 Torr; for 2h; Product distribution / selectivity;
Stage #1: isoxazoline diethyl ester With potassium hydroxide; water In ethanol at 20℃;
Stage #2: With hydrogen; 5%-palladium/activated carbon In ethanol; water at 20℃; under 3750.38 Torr; for 2h; Product distribution / selectivity;
isoxazoline diethyl ester

isoxazoline diethyl ester

A

(2R,4R)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
400769-81-5

(2R,4R)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

B

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Stage #1: isoxazoline diethyl ester With potassium hydroxide; water; sponge nickel catalyst A-7063 In ethanol at 21℃; for 0.0833333h; Sealed reactor;
Stage #2: With hydrogen In ethanol under 1500.15 - 3750.38 Torr; for 1.41667h; Sealed reactor;
Stage #3: With acetic acid In ethanol at 20℃; for 15h; pH=4.5; Product distribution / selectivity;
(2S,4S) 2-benzyloxycarbonylamino-4-hydroxy-4-carboxy-5-(3-indolyl)pentanoic acid

(2S,4S) 2-benzyloxycarbonylamino-4-hydroxy-4-carboxy-5-(3-indolyl)pentanoic acid

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
With hydrogen; palladium 10% on activated carbon In methanol for 3h; Product distribution / selectivity;
piruvate
57-60-3

piruvate

L-Tryptophan
73-22-3

L-Tryptophan

A

4-hydroxy-4-(3-indolylmethyl)-2-ketoglutaric acid
551958-84-0

4-hydroxy-4-(3-indolylmethyl)-2-ketoglutaric acid

B

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Stage #1: piruvate; L-Tryptophan With magnesium chloride; pyridoxal 5'-phosphate at 30℃; pH=7.5 - 7.8; Inert atmosphere; phosphate buffer; Enzymatic reaction;
Stage #2: With L-alanin at 30℃; pH=7.5 - 7.8; Product distribution / selectivity; Inert atmosphere; Enzymatic reaction;
methyl 2-((1H-indol-3-yl)methyl)-4-(benzyloxycarbonylamino)-5-oxotetrahydrofuran-2-carboxylate
535967-29-4

methyl 2-((1H-indol-3-yl)methyl)-4-(benzyloxycarbonylamino)-5-oxotetrahydrofuran-2-carboxylate

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: palladium 10% on activated carbon; hydrogen; triethylamine / methanol / 1 h / 40 °C / 2250.23 Torr / Sealed vessel; Large scale reaction
2.1: water; potassium hydroxide / methanol / 1 h / 25 °C / Inert atmosphere; Large scale reaction
2.2: pH 6.5 / Large scale reaction
2.3: pH 6.5 / Large scale reaction
View Scheme
2,4-Dinitrofluorobenzene
70-34-8

2,4-Dinitrofluorobenzene

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

(2S,4S)-4-(2,4-Dinitro-phenylamino)-2-(1H-indol-3-ylmethyl)-5-oxo-tetrahydro-furan-2-carboxylic acid

(2S,4S)-4-(2,4-Dinitro-phenylamino)-2-(1H-indol-3-ylmethyl)-5-oxo-tetrahydro-furan-2-carboxylic acid

Conditions
ConditionsYield
With sodium hydrogencarbonate In ethanol; water Ambient temperature;
(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid
146142-94-1

(2S,4S)-2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentane-1,5-dioic acid

Methyl (2S,4S)-2-(indol-3-ylmethyl)-4-(2,4-dinitroanilino)-5-oxo-2,3,4,5-tetrahydrofuran-2-carboxylate
146029-61-0

Methyl (2S,4S)-2-(indol-3-ylmethyl)-4-(2,4-dinitroanilino)-5-oxo-2,3,4,5-tetrahydrofuran-2-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydrogen carbonate / ethanol; H2O / Ambient temperature
2: diethyl ether / 0.5 h
View Scheme

146142-94-1Relevant articles and documents

Monatin and its stereoisomers: Chemoenzymatic synthesis and taste properties

Bassoli, Angela,Borgonovo, Gigliola,Busnelli, Gilberto,Morini, Gabriella,Drew, Michael G. B.

, p. 1652 - 1658 (2005)

The sweet natural compound monatin 1 has two stereogenic centres and the (2S,4S) absolute configuration has been attributed to the natural isomer. We obtained all four stereoisomers as pure compounds by a six-step synthetic sequence. The stereogenic centre at C-4 was introduced stereoselectively by a regio- and enantiospecific enzymatic hydrolysis of the racemic ethyl dicarboxylate 4 using a protease from Aspergillus oryzae. The absolute configuration of the intermediate products was assigned by X-ray diffraction of chiral derivatives. The stereogenic centre at C-2 was introduced non-specifically, and the resulting diastereomeric mixtures were separated by RP-HPLC. The absolute configurations of the final products were established by comparing retention times on a chiral HPLC column with those of known samples. The four stereoisomers were submitted to tasting trials and three of them, particularly the (2R,4R) isomer, were found to be intensely sweet. A sample of natural monatin analysed under the same conditions is shown to contain all the four stereoisomers. The relative stereoisomeric content in the plant, as well as the possible isomerisation of the chiral centres during extraction and manipulation of monatin samples, are important points that need to be clarified by extensive analysis of the natural extracts. Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2005.

Scale-up of a chemo-biocatalytic route to (2 R,4 R)- and (2 S,4 S)-monatin

Rousseau, Amanda L.,Buddoo, Subash R.,Gordon, Gregory E. R.,Beemadu, Sharon,Kupi, B. Godfrey,Lepuru, M. Jerry,Maumela, Munaka C.,Parsoo, Arvesh,Sibiya, Duncan M.,Brady, Dean

, p. 249 - 257 (2011/10/02)

Monatin, a natural sweetener, refers to a collection of four isomers of 2-((1H-indol-3-yl)methyl)-4-amino-2-hydroxypentanedioic acid. A chemo-biocatalytic approach to kilogram quantities of enantiopure 2S,4S-monatin and 2R,4R-monatin from indole is described. Key steps in the process include a (2 + 3) cycloaddition reaction followed by nickel-catalysed reduction to construct the monatin backbone, and a highly selective enzyme resolution of the 2S,4S- and 2R,4R-monatin diastereomeric pair to afford each enantiomer in 99% ee.

PRODUCTION OF MONATIN STEREOISOMERS

-

Page/Page column 17, (2009/05/29)

Methods and materials for the production of the high intensity sweetener, monatin, in stereoisomerically-pure or stereoisomerically-enriched form are disclosed. For example, methods using stereoisoselective hydrolysis and separation of a monatin-derived lactone ester are disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 146142-94-1